Literature DB >> 25046398

PACHYCHOROID: an inherited condition?

Mathieu Lehmann1, Elodie Bousquet, Talal Beydoun, Francine Behar-Cohen.   

Abstract

PURPOSE: Thick choroid (pachychoroid) is associated with central serous chorioretinopathy (CSC), but whether pachychoroid is inherited is unknown.
METHODS: In a prospective observational study, first- or second-degree relatives (16 individuals) of 5 patients with CSC had refraction and visual acuity measurement, fundus examination, nonmydriatic photography, and autofluorescence photography. Eyes were graded using the following criteria: 0: normal fundus and autofluorescence photography, 1: focal retinal pigment epithelium hyperfluorescence and/or hypofluorescence and/or retinal pigment epithelial detachment, 2: CSC or diffuse retinal epitheliopathy. Choroid thickness was measured by enhanced depth imaging mode on optical coherence tomography.
RESULTS: Considering 395 μm as the threshold limit for normal subfoveal choroidal thickness, 50% of the eyes from relatives had a thick choroid. Nine eyes of Grade 0 (28%) with an isolated pachychoroid would thus have been considered normal, if choroidal thickness was not included as a screening sign predisposing for CSC.
CONCLUSION: Our observation suggests that pachychoroid could be an inherited condition with potentially a dominant transmission mode. Its inclusion in the phenotype of CSC for genetic studies should be considered.

Entities:  

Mesh:

Year:  2015        PMID: 25046398     DOI: 10.1097/IAE.0000000000000287

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  39 in total

1.  Sensitivity and specificity of choroidal thickness measurement by EDI-OCT for central serous chorioretinopathy diagnosis.

Authors:  Javier Orduña-Azcona; Elia Pérez-Fernández; Ana M Guadilla; Sofía De Manuel-Triantafilo; Laura Modamio; Pablo Gili
Journal:  Int Ophthalmol       Date:  2020-09-04       Impact factor: 2.031

2.  The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography.

Authors:  Francesco Pichi; Mariachiara Morara; Chiara Veronese; Antonio P Ciardella
Journal:  Int Ophthalmol       Date:  2017-05-11       Impact factor: 2.031

Review 3.  Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.

Authors:  Francesco Sartini; Michele Figus; Giamberto Casini; Marco Nardi; Chiara Posarelli
Journal:  Int Ophthalmol       Date:  2020-07-30       Impact factor: 2.031

4.  [Uniform classification of the pachychoroid spectrum disorders].

Authors:  Alaa Din Abdin; Shady Suffo; Fabian N Fries; Hakan Kaymak; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-04-26       Impact factor: 1.059

5.  The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography.

Authors:  Sibel Demirel; Özge Yanık; Hilal Nalcı; Figen Batıoğlu; Emin Özmert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-11       Impact factor: 3.117

6.  Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.

Authors:  Zhi-Qiao Liang; Lyu-Zhen Huang; Jin-Feng Qu; Ming-Wei Zhao
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

Review 7.  Spectrum of pachychoroid diseases.

Authors:  Sezen Akkaya
Journal:  Int Ophthalmol       Date:  2017-08-01       Impact factor: 2.031

8.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

Review 9.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

Review 10.  Pachychoroid disease.

Authors:  Chui Ming Gemmy Cheung; Won Ki Lee; Hideki Koizumi; Kunal Dansingani; Timothy Y Y Lai; K Bailey Freund
Journal:  Eye (Lond)       Date:  2018-07-11       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.